In conclusion we have discovered that BRD4-bound super-enhancers provide a powerful tool for enriching and prioritizing PC and BC genetic risk loci (Fig. 4), and have shown that key TFs such as AR or ER, despite being pivotal tissue-specific TFs, do not contribute to tissue-specific genetic risk enrichment more than epigenetic factors. This evidence concerns the gene AR and breast cancer.